James O. Shaw

1.5k total citations
23 papers, 1.3k citations indexed

About

James O. Shaw is a scholar working on Immunology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, James O. Shaw has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Pharmacology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in James O. Shaw's work include Inflammatory mediators and NSAID effects (4 papers), Complement system in diseases (3 papers) and Toxin Mechanisms and Immunotoxins (3 papers). James O. Shaw is often cited by papers focused on Inflammatory mediators and NSAID effects (4 papers), Complement system in diseases (3 papers) and Toxin Mechanisms and Immunotoxins (3 papers). James O. Shaw collaborates with scholars based in United States. James O. Shaw's co-authors include R. Neal Pinckard, D J Hanahan, Linda M. McManus, Peter M. Henson, Roger M. Lyons, Thasia Woodworth, A. B. Deisseroth, Michael G. Rosenblum, C Meneghetti and K Parker and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

James O. Shaw

23 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James O. Shaw United States 18 483 274 204 191 155 23 1.3k
Ward Pa United States 20 431 0.9× 315 1.1× 159 0.8× 146 0.8× 70 0.5× 42 1.2k
LA Boxer United States 22 670 1.4× 437 1.6× 215 1.1× 180 0.9× 54 0.3× 57 1.6k
Gary Jesmok United States 17 621 1.3× 598 2.2× 228 1.1× 232 1.2× 75 0.5× 42 1.8k
Mark P. Fletcher United States 20 683 1.4× 465 1.7× 176 0.9× 81 0.4× 68 0.4× 44 1.8k
Fumihiko Takatsuki Japan 16 496 1.0× 287 1.0× 192 0.9× 98 0.5× 90 0.6× 24 1.5k
Alfonso Oriente Italy 16 455 0.9× 322 1.2× 225 1.1× 100 0.5× 55 0.4× 32 1.2k
Zarin Brown United Kingdom 20 813 1.7× 482 1.8× 325 1.6× 196 1.0× 85 0.5× 38 2.1k
E.‐M. Lemmel Germany 21 388 0.8× 181 0.7× 106 0.5× 73 0.4× 86 0.6× 56 1.2k
Tetsuro Okabe Japan 24 245 0.5× 582 2.1× 159 0.8× 181 0.9× 70 0.5× 73 1.5k
Jon Lewis United States 17 260 0.5× 197 0.7× 158 0.8× 139 0.7× 40 0.3× 58 1.1k

Countries citing papers authored by James O. Shaw

Since Specialization
Citations

This map shows the geographic impact of James O. Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James O. Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James O. Shaw more than expected).

Fields of papers citing papers by James O. Shaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James O. Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James O. Shaw. The network helps show where James O. Shaw may publish in the future.

Co-authorship network of co-authors of James O. Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of James O. Shaw. A scholar is included among the top collaborators of James O. Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James O. Shaw. James O. Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
LeMaistre, CF, C Meneghetti, Michael G. Rosenblum, et al.. (1992). Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor. Blood. 79(10). 2547–2554. 104 indexed citations
2.
LeMaistre, CF, C Meneghetti, Michael G. Rosenblum, et al.. (1992). Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor. Blood. 79(10). 2547–2554. 134 indexed citations
3.
Weinberg, Adriana, James O. Shaw, Verner Paetkau, et al.. (1988). Cloning of cDNA for the bovine IL-2 receptor (bovine Tac antigen).. PubMed. 63(4). 603–10. 28 indexed citations
4.
Shaw, James O. & P M Henson. (1982). Pulmonary intravascular sequestration of activated neutrophils: failure to induce light-microscopic evidence of lung injury in rabbits.. PubMed. 108(1). 17–23. 24 indexed citations
5.
Shaw, James O., et al.. (1982). Extra- and intracellular Ca2+ requirements for lysosomal enzyme secretion in human neutrophils. Inflammation Research. 12(3). 328–332. 9 indexed citations
6.
Shaw, James O., et al.. (1982). Thromboxane B2 and prostaglandin E2 in the rat kidney with unilateral ureteral obstruction. American Journal of Physiology-Renal Physiology. 242(3). F220–F225. 28 indexed citations
7.
Fine, Richard Ν., et al.. (1981). Effects of C5a on baboon alveolar macrophage migration.. PubMed. 123(1). 110–14. 16 indexed citations
8.
Shaw, James O., et al.. (1981). Activation of rabbit platelet phospholipase and thromboxane synthesis by 1-o-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet activating factor). Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 663(1). 222–229. 69 indexed citations
9.
Shaw, James O., et al.. (1981). Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).. The Journal of Immunology. 127(3). 1250–1255. 335 indexed citations
10.
11.
Beck, Nama & James O. Shaw. (1981). Thromboxane B2 and prostaglandin E2 in the K+-depleted rat kidney. American Journal of Physiology-Renal Physiology. 240(2). F151–F157. 20 indexed citations
12.
McManus, Linda M., James O. Shaw, & R. Neal Pinckard. (1980). Thromboxane B2 (TxB2) release during IgE anaphylaxis in the rabbit.. The Journal of Immunology. 125(5). 1950–1954. 26 indexed citations
13.
Shaw, James O. & Peter M. Henson. (1980). The binding of rabbit basophil-derived platelet-activating factor to rabbit platelets.. PubMed. 98(3). 791–810. 35 indexed citations
14.
Lyons, Roger M. & James O. Shaw. (1980). Interaction of Ca2+ and protein phosphorylation in the rabbit platelet release reaction.. Journal of Clinical Investigation. 65(2). 242–255. 54 indexed citations
15.
Pinckard, R. Neal, Linda M. McManus, Constantinos A. Demopoulos, et al.. (1980). Molecular pathobiology of acetyl glyceryl ether phosphorylcholine: evidence for the structural and functional identity with platelet-activating factor.. PubMed. 28(Suppl). 95s–103s. 31 indexed citations
16.
Henson, Peter M., Karin M. McCarthy, Gary L. Larsen, et al.. (1979). Complement fragments, alveolar macrophages, and alveolitis.. PubMed. 97(1). 93–110. 106 indexed citations
17.
Shaw, James O., Morton P. Printz, K. Hirabayashi, & Peter M. Henson. (1978). Role of Prostaglandin Synthesis in Rabbit Platelet Activation Induced by Basophil-Derived Platelet-Activating Factor. The Journal of Immunology. 121(5). 1939–1945. 35 indexed citations
18.
Pinckard, R. Neal, Marilyn Halonen, John D. Palmer, et al.. (1977). Intravascular Aggregation and Pulmonary Sequestration of Platelets during IgE-Induced Systemic Anaphylaxis in the Rabbit: Abrogation of Lethal Anaphylactic Shock by Platelet Depletion. The Journal of Immunology. 119(6). 2185–2193. 118 indexed citations
19.
Shaw, James O. & Kenneth Μ. Moser. (1975). The Current Status of Prostaglandins and the Lungs. CHEST Journal. 68(1). 75–80. 22 indexed citations
20.
Breen, Kerry J., et al.. (1971). The Acute Effect of Alcohol on Hepatic Coenzyme A and Acetyl CoA Concentrations. Experimental Biology and Medicine. 138(3). 1096–1100. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ward Pa Breakdown of academic impact, for papers by LA Boxer Breakdown of academic impact, for papers by Gary Jesmok Breakdown of academic impact, for papers by Mark P. Fletcher Breakdown of academic impact, for papers by Fumihiko Takatsuki Breakdown of academic impact, for papers by Alfonso Oriente Breakdown of academic impact, for papers by Zarin Brown Breakdown of academic impact, for papers by E.‐M. Lemmel Breakdown of academic impact, for papers by Tetsuro Okabe Breakdown of academic impact, for papers by Jon Lewis
Rankless by CCL
2026